Sign in

CIK 0001759425 · Large accelerated filer

Mirum Pharmaceuticals, Inc.

Sign in to watch
Ticker
MIRM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831281555
Phone
650-667-4085
Business address
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Planned sale CHIEF FINANCIAL OFFICER sold 5,000 shares at an average $93.82 ($469,077)
  7. 4 Option exercise PRESIDENT AND COO acquired 16,988 shares (option exercise)
  8. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 30,000 shares at an average $95.84 ($2,875,103)
  9. 4 Option exercise Director acquired 3,977 shares (option exercise)
  10. 4 Option exercise Director acquired 3,977 shares (option exercise)
  11. 4 Open-market sale Director sold 3,977 shares at $100.00 ($397,700)
  12. 4 Option exercise Director acquired 3,977 shares (option exercise)
  13. 4 Planned sale Director sold 2,000 shares at $109.47 ($218,940)
  14. 4 Planned sale Director sold 2,000 shares at $96.90 ($193,800)
  15. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 7,287 shares at $91.98 ($670,243)
  16. 4 Open-market sale CHIEF MEDICAL OFFICER sold 7,287 shares at $91.98 ($670,243)
  17. 4 Planned sale Director sold 2,000 shares at $90.76 ($181,520)
  18. 4 Open-market sale PRESIDENT AND COO sold 16,515 shares at $91.98 ($1,519,015)
  19. 4 Open-market sale SVP, GLOBAL CONTROLLER sold 4,732 shares at $91.98 ($435,239)
  20. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 40,985 shares at $91.98 ($3,769,714)

Page 2 of 18 · 355 filings